Martin Ester

Martin Ester

Auto-generated profile, based on publicly available information

Martin Ester

Simon Fraser University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2017 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
THTong He
Tong He
MHMarten Heidemeyer
Marten Heidemeyer
FBFuqiang Ban
Fuqiang Ban
ACArtem Cherkasov
Artem Cherkasov
MEMartin Ester
Martin Ester
Computational prediction of the interaction between drugs and targets is a standing challenge in the field of drug discovery. A number of rather accurate predictions were reported for various binary drug–target benchmark datasets. However, a notable drawback of a binary representation of interaction data is that missing endpoints for non-interacting drug–target pairs are not differentiated from inactive cases, and that predicted levels of activity depend on pre-defined binarization thresholds. In this paper, we present a method called SimBoost that predicts continuous (non-binary) values of binding affinities of compounds and proteins and thus incorporates the whole interaction spectrum from true negative to true positive interactions. Additionally, we propose a version of the method called SimBoostQuant which computes a prediction interval in order to assess the confidence of the predicted affinity, thus defining the Applicability Domain metrics explicitly. We evaluate SimBoost and SimBoostQuant on two established drug–target interaction benchmark datasets and one new dataset that we propose to use as a benchmark for read-across cheminformatics applications. We demonstrate that our methods outperform the previously reported models across the studied datasets.

5 July 2019 in Bioinformatics
Verified
Journal Article
Open access
PDF file
HSHossein Sharifi-Noghabi
Hossein Sharifi-Noghabi
OZOlga Zolotareva
Olga Zolotareva
CCColin Collins
Colin Collins
MEMartin Ester
Martin Ester
Historically, gene expression has been shown to be the most informative data for drug response prediction. Recent evidence suggests that integrating additional omics can improve the prediction accuracy which raises the question of how to integrate the additional omics. Regardless of the integration strategy, clinical utility and translatability are crucial. Thus, we reasoned a multi-omics approach combined with clinical datasets would improve drug response prediction and clinical relevance. We propose MOLI, a multi-omics late integration method based on deep neural networks. MOLI takes somatic mutation, copy number aberration and gene expression data as input, and integrates them for drug response prediction. MOLI uses type-specific encoding sub-networks to learn features for each omics type, concatenates them into one representation and optimizes this representation via a combined cost function consisting of a triplet loss and a binary cross-entropy loss. The former makes the representations of responder samples more similar to each other and different from the non-responders, and the latter makes this representation predictive of the response values. We validate MOLI on in vitro and in vivo datasets for five chemotherapy agents and two targeted therapeutics. Compared to state-of-the-art single-omics and early integration multi-omics methods, MOLI achieves higher prediction accuracy in external validations. Moreover, a significant improvement in MOLI’s performance is observed for targeted drugs when training on a pan-drug input, i.e. using all the drugs with the same target compared to training only on drug-specific inputs. MOLI’s high predictive power suggests it may have utility in precision oncology. https://github.com/hosseinshn/MOLI. Supplementary data are available at Bioinformatics online.

11 November 2024 in ACM Computing Surveys
Verified
Journal Article
Open access
SZSheng Zhou
Sheng Zhou
HXHONGJIA XU
HONGJIA XU
ZZZhuonan Zheng
Zhuonan Zheng
JCJiawei Chen
Jiawei Chen
ZLZhao Li
Zhao Li
MEMartin Ester
Martin Ester
Clustering is a fundamental machine learning task, which aim at assigning instances into groups so that similar samples belong to the same cluster while dissimilar samples belong to different clusters. Shallow clustering methods usually assume that data are collected and expressed as feature vectors within which clustering is performed. However, clustering high-dimensional data, such as images, texts, videos, and graphs, poses significant challenges for clustering tasks, such as indiscriminate representation and intricate relationships among instances. Over the past decades, deep learning has achieved remarkable success in effective representation learning and modeling complex relationships. Motivated by these advancements, Deep Clustering seeks to improve clustering outcomes through deep learning techniques, garnering considerable interest from both academia and industry. Despite many contributions to this vibrant area of research, the lack of systematic analysis and a comprehensive taxonomy has hindered progress in this field. In this survey, we first explore how deep learning can be integrated into deep clustering and identify two fundamental components: the representation learning module and the clustering module. Then, we summarize and analyze the representative design of these two modules. Furthermore, we introduce a novel taxonomy of deep clustering based on how these two modules interact, specifically through multistage, generative, iterative, and simultaneous approaches. In addition, we present well-known benchmark datasets, evaluation metrics, and open-source tools to clearly demonstrate different experimental approaches. Finally, we examine the practical applications of deep clustering and propose challenging areas for future research.

18 June 2021 in IEEE Transactions on Knowledge and Data Engineering
Verified
Journal Article
Closed access
ZZZhen Zhang
Zhen Zhang
JBJiajun Bu
Jiajun Bu
MEMartin Ester
Martin Ester
JZJianfeng Zhang
Jianfeng Zhang
ZLZhao Li
Zhao Li
CWCan Wang
Can Wang
Graph Neural Networks (GNNs), which generalize deep neural networks to graph-structured data, have drawn considerable attention and achieved state-of-the-art performance in numerous graph related tasks. However, existing GNN models mainly focus on designing graph convolution operations. The graph pooling (or downsampling) operations, that play an important role in learning hierarchical representations, are usually overlooked. In this paper, we proposed a novel multi-view graph pooling operator dubbed as MVPool, which ranks nodes across different views with different contextual graph information. Meanwhile, attention mechanism is utilized to promote the collaboration of different views for generating robust node rankings. Then the pooling operation adaptively selects a subset of nodes to form an induced subgraph based on the ranking list. To preserve the underlying graph topological information, we further introduce a structure learning mechanism to learn a refined graph structure for the pooled graph at each layer. The proposed MVPool operator is a general strategy that can be integrated into various graph neural network architectures. By combining MVPool operator with graph neural networks, we perform hierarchical representation learning for both node and graph level classification as well as clustering tasks. Experimental results on nine widely used benchmarks demonstrate the effectiveness of our proposed model.

9 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAli Arab
Ali Arab
BCBetty Chinda
Betty Chinda
GMGeorge Medvedev
George Medvedev
WSWilliam Siu
William Siu
HGHui Guo
Hui Guo
XSXiaowei Song
Xiaowei Song
This project aimed to develop and evaluate a fast and fully-automated deep-learning method applying convolutional neural networks with deep supervision (CNN-DS) for accurate hematoma segmentation and volume quantification in computed tomography (CT) scans. Non-contrast whole-head CT scans of 55 patients with hemorrhagic stroke were used. Individual scans were standardized to 64 axial slices of 128 × 128 voxels. Each voxel was annotated independently by experienced raters, generating a binary label of hematoma versus normal brain tissue based on majority voting. The dataset was split randomly into training (n = 45) and testing (n = 10) subsets. A CNN-DS model was built applying the training data and examined using the testing data. Performance of the CNN-DS solution was compared with three previously established methods. The CNN-DS achieved a Dice coefficient score of 0.84 ± 0.06 and recall of 0.83 ± 0.07, higher than patch-wise U-Net (< 0.76). CNN-DS average running time of 0.74 ± 0.07 s was faster than PItcHPERFeCT (> 1412 s) and slice-based U-Net (> 12 s). Comparable interrater agreement rates were observed between “method-human” vs. “human–human” (Cohen’s kappa coefficients > 0.82). The fully automated CNN-DS approach demonstrated expert-level accuracy in fast segmentation and quantification of hematoma, substantially improving over previous methods. Further research is warranted to test the CNN-DS solution as a software tool in clinical settings for effective stroke management.

11 August 2021 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
HSHossein Sharifi-Noghabi
Hossein Sharifi-Noghabi
SJSoheil Jahangiri-Tazehkand
Soheil Jahangiri-Tazehkand
PSPetr Smirnov
Petr Smirnov
CHCasey Hon
Casey Hon
AMAnthony Mammoliti
Anthony Mammoliti
BHBenjamin Haibe-Kains
Benjamin Haibe-Kains
The goal of precision oncology is to tailor treatment for patients individually using the genomic profile of their tumors. Pharmacogenomics datasets such as cancer cell lines are among the most valuable resources for drug sensitivity prediction, a crucial task of precision oncology. Machine learning methods have been employed to predict drug sensitivity based on the multiple omics data available for large panels of cancer cell lines. However, there are no comprehensive guidelines on how to properly train and validate such machine learning models for drug sensitivity prediction. In this paper, we introduce a set of guidelines for different aspects of training gene expression-based predictors using cell line datasets. These guidelines provide extensive analysis of the generalization of drug sensitivity predictors and challenge many current practices in the community including the choice of training dataset and measure of drug sensitivity. The application of these guidelines in future studies will enable the development of more robust preclinical biomarkers.